Department of Developmental Biology and Cancer Research, Institute for Medical Research-Israel-Canada, Hadassah School of Medicine, The Hebrew University of Jerusalem, Israel.
Cancer Res. 2013 May 1;73(9):2829-39. doi: 10.1158/0008-5472.CAN-12-3730. Epub 2013 Feb 19.
Cellular senescence, a state of cell-cycle arrest accompanied by dramatic morphologic and metabolic changes, is a central means by which cells respond to physiologic stress and oncogene activity. Senescence is thought to play important roles in aging and in tumor suppression, yet the dynamics by which senescent cells are formed, their effects on tissue function and their eventual fate are poorly understood. To study cellular senescence within an adult tissue, we developed transgenic mice inducibly expressing p14(ARF) (human ortholog of murine p19(ARF)), a central activator of senescence. Induction of p14(ARF) in the epidermis rapidly led to widespread apoptosis and cell-cycle arrest, a stage that was transient, and was followed by p53-dependent cellular senescence. The endogenous Cdkn2a products p19(ARF) and p16(Ink4a) were activated by the transgenic p14(ARF) through p53, revealing a senescence-promoting feed-forward loop. Commitment of cells to senescence required continued p14(ARF) expression, indicating that entry into this state depends on a persistent signal. However, once formed, senescent cells were retained in the epidermis, often for weeks after transgene silencing, indicating an absence of an efficient rapidly acting mechanism for their removal. Stem cells in the hair follicle bulge were largely protected from apoptosis upon p14(ARF) induction, but irreversibly lost their ability to proliferate and initiate follicle growth. Interestingly, induction of epidermal hyperplasia prevented the appearance of senescent cells upon p14(ARF) induction. Our findings provide basic insights into the dynamics of cellular senescence, a central tumor- suppressive mechanism, and reveal the potential for prolonged retention of senescent cells within tissues.
细胞衰老,是一种细胞周期停滞伴随显著形态和代谢变化的状态,是细胞对生理应激和癌基因活性的主要反应方式。衰老被认为在衰老和肿瘤抑制中发挥重要作用,但衰老细胞形成的动态、它们对组织功能的影响及其最终命运还知之甚少。为了在成年组织中研究细胞衰老,我们开发了可诱导表达 p14(ARF)(鼠 p19(ARF)的人同源物)的转基因小鼠,p14(ARF)是衰老的核心激活物。p14(ARF)在表皮中的诱导迅速导致广泛的细胞凋亡和细胞周期停滞,这是一个短暂的阶段,随后是 p53 依赖性细胞衰老。内源性 Cdkn2a 产物 p19(ARF)和 p16(Ink4a)通过 p53 被转基因 p14(ARF)激活,揭示了一个促进衰老的正反馈环。细胞向衰老的承诺需要持续的 p14(ARF)表达,表明进入这种状态取决于持续的信号。然而,一旦形成,衰老细胞就会保留在表皮中,即使在转基因沉默后数周仍会保留,表明缺乏有效的快速清除机制。毛囊隆起中的干细胞在 p14(ARF)诱导后大部分免受细胞凋亡,但不可逆地失去了增殖和启动毛囊生长的能力。有趣的是,表皮增生的诱导阻止了 p14(ARF)诱导后衰老细胞的出现。我们的研究结果为细胞衰老的动力学提供了基本的见解,细胞衰老作为一种主要的肿瘤抑制机制,揭示了组织中衰老细胞长期保留的潜力。